220 related articles for article (PubMed ID: 9501951)
1. A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort.
LoCascio V; Ballanti P; Milani S; Bertoldo F; LoCascio C; Zanolin EM; Bonucci E
Calcif Tissue Int; 1998 Mar; 62(3):199-204. PubMed ID: 9501951
[TBL] [Abstract][Full Text] [Related]
2. Effects of prednisone and deflazacort on vertebral bone mass.
Gennari C; Imbimbo B
Calcif Tissue Int; 1985 Dec; 37(6):592-3. PubMed ID: 3937579
[TBL] [Abstract][Full Text] [Related]
3. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
Cacoub P; Chemlal K; Khalifa P; Wechsler B; De Gennes C; Belmatoug N; Cohen P; Ziza JM; Verdoncq B; Piette JC
J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of deflazacort and prednisone on rates of mineralization and bone formation.
Lo Cascio V; Kanis JA; Beneton MN; Bertoldo F; Adami S; Poggi G; Zanolin ME
Calcif Tissue Int; 1995 Feb; 56(2):109-12. PubMed ID: 7736317
[TBL] [Abstract][Full Text] [Related]
6. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis.
Messina OD; Barreira JC; Zanchetta JR; Maldonado-Cocco JA; Bogado CE; Sebastián ON; Flores D; Riopedre AM; Redondo G; Lázaro A
J Rheumatol; 1992 Oct; 19(10):1520-6. PubMed ID: 1464862
[TBL] [Abstract][Full Text] [Related]
7. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
Montecucco C; Caporali R; Caprotti P; Caprotti M; Notario A
J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
[TBL] [Abstract][Full Text] [Related]
8. [Glucocorticoids and risk of osteoporosis. On the problem of equivalent dose of desirable and undesirable effects of various glucocorticoids, exemplified by deflazacort].
Rotenberger J; Köbberling J
Med Klin (Munich); 1993 Jul; 88(7):432-7. PubMed ID: 8377721
[No Abstract] [Full Text] [Related]
9. Deflazacort. A review of its pharmacological properties and therapeutic efficacy.
Markham A; Bryson HM
Drugs; 1995 Aug; 50(2):317-33. PubMed ID: 8521761
[TBL] [Abstract][Full Text] [Related]
10. A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders.
Gray RE; Doherty SM; Galloway J; Coulton L; de Broe M; Kanis JA
Arthritis Rheum; 1991 Mar; 34(3):287-95. PubMed ID: 2003854
[TBL] [Abstract][Full Text] [Related]
11. Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies.
Chavassieux PM; Arlot ME; Roux JP; Portero N; Daifotis A; Yates AJ; Hamdy NA; Malice MP; Freedholm D; Meunier PJ
J Bone Miner Res; 2000 Apr; 15(4):754-62. PubMed ID: 10780867
[TBL] [Abstract][Full Text] [Related]
12. Does alternate-day cloprednol therapy prevent bone loss? A longitudinal double-blind, controlled clinical study.
Medici TC; Rüegsegger P
Clin Pharmacol Ther; 1990 Oct; 48(4):455-66. PubMed ID: 2225706
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
Loftus J; Allen R; Hesp R; David J; Reid DM; Wright DJ; Green JR; Reeve J; Ansell BM; Woo PM
Pediatrics; 1991 Sep; 88(3):428-36. PubMed ID: 1881719
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of glucocorticoids on calcium absorption and bone mass.
Gennari C
Br J Rheumatol; 1993 May; 32 Suppl 2():11-4. PubMed ID: 8495275
[TBL] [Abstract][Full Text] [Related]
15. The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis.
Rizzato G; Riboldi A; Imbimbo B; Torresin A; Milani S
Respir Med; 1997 Sep; 91(8):449-60. PubMed ID: 9338047
[TBL] [Abstract][Full Text] [Related]
16. Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients.
Gonnelli S; Rottoli P; Cepollaro C; Pondrelli C; Cappiello V; Vagliasindi M; Gennari C
Calcif Tissue Int; 1997 Nov; 61(5):382-5. PubMed ID: 9351879
[TBL] [Abstract][Full Text] [Related]
17. Bone loss in response to long-term glucocorticoid therapy.
LoCascio V; Bonucci E; Imbimbo B; Ballanti P; Adami S; Milani S; Tartarotti D; DellaRocca C
Bone Miner; 1990 Jan; 8(1):39-51. PubMed ID: 2306553
[TBL] [Abstract][Full Text] [Related]
18. Deflazacort in the treatment of uveitis: a comparative study versus prednisone.
Cerqueti Piera M; Saccà Sergio C; Allegri P; Ciurlo G; Zingirian M; Buscaglia S; Ciprandi G
Allergol Immunopathol (Madr); 1993; 21(3):107-10. PubMed ID: 8356936
[TBL] [Abstract][Full Text] [Related]
19. Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
Guglieri M; Bushby K; McDermott MP; Hart KA; Tawil R; Martens WB; Herr BE; McColl E; Speed C; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Willis T; Griggs RC; ; Straub V; van Ruiten H; Childs AM; Ciafaloni E; Shieh PB; Spinty S; Maggi L; Baranello G; Butterfield RJ; Horrocks IA; Roper H; Alhaswani Z; Flanigan KM; Kuntz NL; Manzur A; Darras BT; Kang PB; Morrison L; Krzesniak-Swinarska M; Mah JK; Mongini TE; Ricci F; von der Hagen M; Finkel RS; O'Reardon K; Wicklund M; Kumar A; McDonald CM; Han JJ; Joyce N; Henricson EK; Schara-Schmidt U; Gangfuss A; Wilichowski E; Barohn RJ; Statland JM; Campbell C; Vita G; Vita GL; Howard JF; Hughes I; McMillan HJ; Pegoraro E; Bello L; Burnette WB; Thangarajh M; Chang T
JAMA; 2022 Apr; 327(15):1456-1468. PubMed ID: 35381069
[TBL] [Abstract][Full Text] [Related]
20. Deflazacort versus methylprednisolone in polymyalgia rheumatica: clinical equivalence and relative antiinflammatory potency of different treatment regimens.
Di Munno O; Imbimbo B; Mazzantini M; Milani S; Occhipinti G; Pasero G
J Rheumatol; 1995 Aug; 22(8):1492-8. PubMed ID: 7473472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
